Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 1 day 30 min ago
Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch
Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch 3/19/2024
Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis
Regeneron Wins Appeal in Eylea-Lucentis Antitrust Case Against Novartis 3/19/2024
Report: 2024 U.S. Life Sciences Salary Trends
Report: 2024 U.S. Life Sciences Salary Trends 3/19/2024
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need 3/18/2024
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data 3/18/2024
J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline
J&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline 3/18/2024
Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon
Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon 3/18/2024
AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer
AstraZeneca Caps US Inhaler Out-of-Pocket Costs on Heels of Boehringer 3/18/2024
Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies
Madrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies 3/18/2024
FDA Action Alert: Orchard, ITF, Merck and More
FDA Action Alert: Orchard, ITF, Merck and More 3/18/2024
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now?
Opinion: I Know I Want to Implement AI in My Company’s R&D. What Now? 3/18/2024
FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma
FDA Adcomm Backs J&J’s Carvykti, BMS’s Abecma Early in Multiple Myeloma 3/15/2024
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data
Merck’s Keytruda Pushes Towards Earlier Stages of Cervical Cancer with Phase III Data 3/15/2024
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
Biotheus, Hansoh Expand Partnership in $694M ADC Deal 3/15/2024
Astellas Backs Out of Potential $340M Licensing Deal with Cartesian
Astellas Backs Out of Potential $340M Licensing Deal with Cartesian 3/15/2024
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets
Bayer, AI-Focused Aignostics Partner to Find New Oncology Targets 3/15/2024
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer 3/15/2024
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia 3/15/2024
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma 3/15/2024
NASH or MASH: No Matter What You Call It, Madrigal’s FDA Approval Is a Big Deal
NASH or MASH: No Matter What You Call It, Madrigal’s FDA Approval Is a Big Deal 3/15/2024
World Pharma News
- Researchers develop a new way to safely boost immune cells to fight cancer
- How the Birmingham Drug Discovery Hub created an investment-ready 'drug library'
- Common HIV treatments may aid Alzheimer's disease patients
- AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson's disease
- Next-generation treatments hitch a ride into cancer cells